Background and Objectives：Phasic coronary flow velocity patterns and microvascular integrities are known to be prognostic factors in acute myocardial infarction (AMI). The use of a distal protection device during primary percutaneous coronary intervention (PCI) may preserve the microvascular integrity of the myocardium by preventing distal embolization of thrombotic materials. This study assessed the effects of such a device on microvascular integrity preservation through Doppler studies of the coronary flow velocities in AMI patients treated with primary PCI. Subjects and Methods：A total of fifty-eight consecutive patients (mean age 54±15, 46 males) with ST segment-elevated AMI, who had undergone primary PCI within 24 hours after onset, were enrolled in the study. The subjects were divided into two groups: 30 patients with the PurcuSurge GuardWire Temporary Occlusion and Aspiration System and 28 without. The TIMI flows and TMP grades (TIMI myocardial perfusion grade) were evaluated. The coronary flow velocities were measured after PCI with a Doppler wire at the baseline, and also after intracoronary adenosine (24-48 μg) induced hyperemia. The coronary flow velocity reserve (CFR), diastolic deceleration time (DDT) and microvascular resistance index (MVRI) were calculated. Results：Between the two groups, no significant differences were found in the angiographic characteristics and CFR. In patients with a distal protection device, however, the post-PCI TMP grades were more favorable (TMP 0/1: 13.3%, TMP 2: 23.3%, TMP 3: 63.4% vs. TMP 0/1: 35.7%, TMP 2: 35.7%, TMP 3: 28.6%, p=0.023), with TMP grade 3 being most common (63.4% vs. 28.6%, p=0.010). These patients also exhibited lower bMVRI and hMVRI levels (4.33±2.22 vs. 5.55±2.36 mmHg · m
Introduction
Acute myocardial infarction(AMI) is commonly related with thrombotic occlusion following a plaque rupture. Accordingly, early relief of the occluded coronary artery and restoration of the coronary flow to the jeopardized myocardium have been demonstrated to decrease mortality and adverse outcomes. [1] [2] [3] Primary percutaneous coronary intervention (PCI), with stent deployment, in AMI cases has been widely performed for restoring the coronary flow to the jeopardized myocardium, a more effective procedure than balloon angioplasty, decreasing the target vessel revascularization and restenosis rate. [4] [5] [6] However, as the distal embolization of ruptured atherosclerotic plaque debris or thrombus is common during primary PCI with catheter-based interventions, stent deployment may also endow a greater chance of distal embolization than balloon angioplasty. 6) Evidence that an obstruction of the distal microvasculature in the downstream bed of the infarct related artery(IRA) is caused by distal embolization of thrombotic materials and platelets during intervention has accumulated. These are critical pathophysiologic events of myocardial infarction, [7] [8] [9] which is subsequently related with slow-flow or no-reflow phenomenon and with additional injury to the microvasculature of the myocardium and poor clinical outcomes. [10] [11] [12] Recanalization and restoration of the epicardial coronary artery will not always guarantee reperfusion at the microvasculature of the myocardium. Therefore, reperfusion of the myocardial tissue level by preserving the microvasculature is crucial, as is opening of the epicardial coronary artery during primary PCI. It has been suggested that a distal embolization protection device may be a feasible, safe and effective tool in preserving the microvasculature of the myocardium due to prevention of distal embolization of thrombotic debris during primary PCI in AMI. [13] [14] [15] [16] The coronary angiographic TIMI myocardial perfusion(TMP) gra- 
Subjects and Methods

Patient population
A total of fifty-eight patients(mean age: 54±15 years; 46 male, 12 female) with first acute ST-segment elevated myocardial infarction, who had experienced primary PCI within 24 hours of symptom onset, were enrolled in this study. 
Procedure
On admission, all patients were pretreated with chewable aspirin(300 mg) and clopidogrel(300-600 mg). An intravenous infusion of heparin was started(1000 U/hr) after a 5000 U intravenous bolus injection, and additional heparin 
Statistical analysis
Results
Clinical characteristics
The study population consisted of 58 consecutive patients, 46 men and 12 women, with a mean age of 54±15 years.
The clinical and laboratory data of both groups are summarized in Table 1 . Of the 58 patients, 38, 17 and 3 had anterior, inferior and 3 lateral wall infarctions, respectively. All patients underwent echocardiography on admission or immediately after primary PCI. The mean ejection fraction was 52.5±
10.3%. The mean time elapsed from symptom onset to reperfusion with primary PCI was 392±228 minutes. There were no significant differences in the clinical characteristics between the two groups, with the exception of the peak cardiac enzymes. The peak CK-MB was lower in group A than in group B patients(256±165 vs. 379±166 μg/mL, p= 0.011). No patient received glycoprotein IIb/IIIa inhibitors before or during PCI. Table 2 and 3 summarize the angiographic data obtained before and after primary PCI. Before and after the primary PCI with stenting, the mean of minimal lumen diameter (MLD), diameter of stenosis(DS) and reference vessel diameter(RVD) were insignificant between the two groups.
Angiographic data
Also, there was no significant difference in the respective TIMI flow grades before intervention(p=0.699)( Table 3) . Table 3) . A significant difference was found in the respective TMP grades between the two groups after the primary PCI(63.4% had TMP grade 3, 23.3% grade 2 and 13.3% grades 0 or 1 in group A vs. 28.6, 35.7 and 35.7%, respectively, in group B, p=0.023)( Table 3) (Fig. 2A) . Further, TMP grade 3 was more common in group A(63.4 vs. 28.6%, p=0.010). In 49 patients who achieved TIMI 3 flow after stenting, TMP grade 3 was also more common in group A (67.9 vs. 38.1%, p=0.048) (Fig. 2B) .
Coronary flow velocity parameters and phasic coronary flow velocity patterns
The heart rate and baseline mean aortic blood pressure were no different between the two groups. The hyperemic mean aortic pressure was lower in Group A than in Group B (74±12 vs. 83±17 mmHg, p=0.026). After the primary PCI, the bAPV and hAPV were higher in group A(21.6± (Table 4) (Fig. 3) .
The comparative phasic coronary flow velocity patterns in cases with and without the distal protection device are illustrated in Fig. 4A , B, respectively.
Discussion
The aim of AMI treatment is the early and sustained reperfusion of the myocardium at risk. As such, primary PCI is widely performed for the restoration of the coronary flow and reperfusion to the jeopardized myocardium. Recently, primary PCI with stent deployment in AMI has been regarded as the optimal therapeutic regimen for the reperfusion of IRA, with lowering of the target vessel revascularization Huang et al 14) reported that a distal protection device with a temporary occlusion system might be feasible, safe and effective during primary angioplasty in AMI. They reported that all patients with such a device had procedural success and exhibited positive results with respect to TMP grades (86.7% of patients achieved TMP grade 3), with none developing an angiographic no-reflow phenomenon. Yip et al 16) reported the PurcuSurge device during primary PCI to be superior to adjunctive tirofiban therapy in terms of the epi- hDDT (msec) 761±256 618±272 0.044 Group A: patient with the PurcuSurge GuardWire, Group B: without the PurcuSurge GuardWire, b, hAPV: baseline, hyperemic average peak velocity, CFR: coronary flow velocity reserve, b, hMVRI: baseline, hyperemic microvascular resistance index, b, hSAPV: baseline, hyperemic systolic average peak velocity, b, hDSVR: baseline, hyperemic diastolic and systolic velocity ratio, b, hDDT: baseline, hyperemic diastolic deceleration time cardial flow, TMP grades and 30-day clinical outcomes. In our study, the post-PCI TMP grades were more favorable in group A than B. TMP grade 3 was also more common in group A and in 49 selected patients with TIMI grade 3 flow after primary PCI, TMP grade 3 was also more common in group A. These results suggested that a distal protection device is more effective in the recovery of reperfusion at the myocardial tissue level, which may be effective in preserving the micorvascular integrity of the myocardium during primary PCI.
The CFR and phasic coronary flow velocity patterns are known to be prognostic factors for left ventricular functional improvement and for the clinical prognosis in AMI. 19 )20)27)28) We directly evaluated the microvascular function by assessing the coronary flow velocity and coronary flow velocity patterns using an intracoronary Doppler wire after primary PCI. In severely damaged myocardium, with diffuse obstruction of the microvasculature due to cell necrosis or multiple microvascular emboli, the distal coronary pressure increased and the coronary flow velocity rapidly decreased as a result of the increased microvascular resistance. Therefore, the increased microvascular resistance after relief of the epicardial stenosis with stenting may be related with severely damaged myocardium and microvascular dysfunction. 12) In group A, the bAPV and hAPV were significantly higher and the bMVRI and hMVRI significantly lower than in group B.
The higher APV and lower MVRI strongly suggested that patients with the distal protection device, compared to those without, had less damage, with preserved microvascular circulation of the infarct-related myocardium, due to the pre- In patient with a distal protection device, the CFR was 1.37 and the coronary flow velocity patterns and microvascular resistance index were favorable. In patients without a distal protection device, the CFR was 1.92 and the coronary flow velocity patterns and microvascular resistance index were unfavorable. Note: the baseline APV of patient with distal protection was higher than that of those without, which might result in a low CFR value. GW: PurcuSurge GuarWire, APV: average peak velocity, SAPV: systolic average peak velocity, MVRI: microvascular resistance index, DDT: diastolic deceleration time, CFR: coronary flow velocity reserve. 
Baseline Hyperemia
Conclusion
This study is the first to show the effectiveness of the PurcuSurge GuardWire system as a distal protection device for preserving the microvascular integrity according to the coronary flow reserve, microvascular resistance indexes and phasic coronary flow velocity patterns using an intracoronary Doppler wire. The distal protection device is feasible and effective in the preservation of the microvascular integrity during primary PCI in AMI patients.
